APO Research
Talk to an analyst

APO RESEARCH · REPORT

Probiotics for Middle-aged and Elderly

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Probiotics for Middle-aged and Elderly Market Analysis and Forecast 2026-2032

5 July 2026206 pages

Choose your research edition.

Industry ResearchProbiotics for Middle-aged and Elderly Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Probiotics for Middle-aged and Elderly Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Probiotics for Middle-aged and Elderly Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Probiotics for Middle-aged and Elderly Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Probiotics for Middle-aged and Elderly Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Probiotics for Middle-aged and Elderly market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Probiotics for Middle-aged and Elderly is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Probiotics for Middle-aged and Elderly is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Probiotics for Middle-aged and Elderly is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Probiotics for Middle-aged and Elderly is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Probiotics for Middle-aged and Elderly include DuPont(Danisco), Chr. Hansen, China-Biotics, Nestle, Danone, BioGaia, OMNi-BiOTiC, Glory Biotech and Ganeden, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Probiotics for Middle-aged and Elderly, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Probiotics for Middle-aged and Elderly, also provides the sales of main regions and countries. Of the upcoming market potential for Probiotics for Middle-aged and Elderly, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Probiotics for Middle-aged and Elderly sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Probiotics for Middle-aged and Elderly market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Probiotics for Middle-aged and Elderly sales, projected growth trends, production technology, application and end-user industry.

Probiotics for Middle-aged and Elderly Segment by Company

DuPont(Danisco)

Chr. Hansen

China-Biotics

Nestle

Danone

BioGaia

OMNi-BiOTiC

Glory Biotech

Ganeden

Morinaga Milk Industry

Sabinsa

Greentech

Bioriginal

Biosearch Life

UAS Laboratories

Synbiotech

Probiotics for Middle-aged and Elderly Segment by Type

Lactic Acid Bacteria

Bifidobacterium

Others

Probiotics for Middle-aged and Elderly Segment by Application

Supermarket

Online Retail

Others

Probiotics for Middle-aged and Elderly Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Probiotics for Middle-aged and Elderly market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Probiotics for Middle-aged and Elderly and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Probiotics for Middle-aged and Elderly.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Probiotics for Middle-aged and Elderly in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Probiotics for Middle-aged and Elderly manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Probiotics for Middle-aged and Elderly sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Probiotics for Middle-aged and Elderly Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Lactic Acid Bacteria Major Manufacturers Table 3. Bifidobacterium Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Probiotics for Middle-aged and Elderly Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Supermarket Major Manufacturers Table 7. Online Retail Major Manufacturers Table 8. Others Major Manufacturers Table 9. Probiotics for Middle-aged and Elderly Industry Trends Table 10. Probiotics for Middle-aged and Elderly Industry Drivers Table 11. Probiotics for Middle-aged and Elderly Industry Opportunities and Challenges Table 12. Probiotics for Middle-aged and Elderly Industry Restraints Table 13. Global Probiotics for Middle-aged and Elderly Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Probiotics for Middle-aged and Elderly Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Probiotics for Middle-aged and Elderly Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Region (2021-2026) Table 17. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Region (2027-2032) Table 18. Global Probiotics for Middle-aged and Elderly Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Probiotics for Middle-aged and Elderly Sales by Region (2021-2026) & (k units) Table 20. Global Probiotics for Middle-aged and Elderly Sales by Region (2027-2032) & (k units) Table 21. Global Probiotics for Middle-aged and Elderly Sales Market Share by Region (2021-2026) Table 22. Global Probiotics for Middle-aged and Elderly Sales Market Share by Region (2027-2032) Table 23. Global Probiotics for Middle-aged and Elderly Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Probiotics for Middle-aged and Elderly Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Probiotics for Middle-aged and Elderly Sales Market Share by Manufacturers (2021-2026) Table 27. Global Probiotics for Middle-aged and Elderly Sales Price (USD/unit) of Manufacturers (2021-2026) Table 28. Global Probiotics for Middle-aged and Elderly Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Probiotics for Middle-aged and Elderly Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Probiotics for Middle-aged and Elderly Manufacturers, Product Type & Application Table 31. Global Probiotics for Middle-aged and Elderly Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Probiotics for Middle-aged and Elderly by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Probiotics for Middle-aged and Elderly Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Probiotics for Middle-aged and Elderly Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Probiotics for Middle-aged and Elderly Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Type (2021-2026) Table 38. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Type (2027-2032) Table 39. Global Probiotics for Middle-aged and Elderly Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Probiotics for Middle-aged and Elderly Sales by Type (2021-2026) & (k units) Table 41. Global Probiotics for Middle-aged and Elderly Sales by Type (2027-2032) & (k units) Table 42. Global Probiotics for Middle-aged and Elderly Sales Market Share by Type (2021-2026) Table 43. Global Probiotics for Middle-aged and Elderly Sales Market Share by Type (2027-2032) Table 44. Global Probiotics for Middle-aged and Elderly Price by Type (2021-2026) & (USD/unit) Table 45. Global Probiotics for Middle-aged and Elderly Price by Type (2027-2032) & (USD/unit) Table 46. Global Probiotics for Middle-aged and Elderly Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Probiotics for Middle-aged and Elderly Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Probiotics for Middle-aged and Elderly Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Application (2021-2026) Table 50. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Application (2027-2032) Table 51. Global Probiotics for Middle-aged and Elderly Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Probiotics for Middle-aged and Elderly Sales by Application (2021-2026) & (k units) Table 53. Global Probiotics for Middle-aged and Elderly Sales by Application (2027-2032) & (k units) Table 54. Global Probiotics for Middle-aged and Elderly Sales Market Share by Application (2021-2026) Table 55. Global Probiotics for Middle-aged and Elderly Sales Market Share by Application (2027-2032) Table 56. Global Probiotics for Middle-aged and Elderly Price by Application (2021-2026) & (USD/unit) Table 57. Global Probiotics for Middle-aged and Elderly Price by Application (2027-2032) & (USD/unit) Table 58. DuPont(Danisco) Company Information Table 59. DuPont(Danisco) Business Overview Table 60. DuPont(Danisco) Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. DuPont(Danisco) Probiotics for Middle-aged and Elderly Product Portfolio Table 62. DuPont(Danisco) Recent Development Table 63. Chr. Hansen Company Information Table 64. Chr. Hansen Business Overview Table 65. Chr. Hansen Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Chr. Hansen Probiotics for Middle-aged and Elderly Product Portfolio Table 67. Chr. Hansen Recent Development Table 68. China-Biotics Company Information Table 69. China-Biotics Business Overview Table 70. China-Biotics Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. China-Biotics Probiotics for Middle-aged and Elderly Product Portfolio Table 72. China-Biotics Recent Development Table 73. Nestle Company Information Table 74. Nestle Business Overview Table 75. Nestle Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Nestle Probiotics for Middle-aged and Elderly Product Portfolio Table 77. Nestle Recent Development Table 78. Danone Company Information Table 79. Danone Business Overview Table 80. Danone Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Danone Probiotics for Middle-aged and Elderly Product Portfolio Table 82. Danone Recent Development Table 83. BioGaia Company Information Table 84. BioGaia Business Overview Table 85. BioGaia Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. BioGaia Probiotics for Middle-aged and Elderly Product Portfolio Table 87. BioGaia Recent Development Table 88. OMNi-BiOTiC Company Information Table 89. OMNi-BiOTiC Business Overview Table 90. OMNi-BiOTiC Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. OMNi-BiOTiC Probiotics for Middle-aged and Elderly Product Portfolio Table 92. OMNi-BiOTiC Recent Development Table 93. Glory Biotech Company Information Table 94. Glory Biotech Business Overview Table 95. Glory Biotech Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Glory Biotech Probiotics for Middle-aged and Elderly Product Portfolio Table 97. Glory Biotech Recent Development Table 98. Ganeden Company Information Table 99. Ganeden Business Overview Table 100. Ganeden Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Ganeden Probiotics for Middle-aged and Elderly Product Portfolio Table 102. Ganeden Recent Development Table 103. Morinaga Milk Industry Company Information Table 104. Morinaga Milk Industry Business Overview Table 105. Morinaga Milk Industry Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Morinaga Milk Industry Probiotics for Middle-aged and Elderly Product Portfolio Table 107. Morinaga Milk Industry Recent Development Table 108. Sabinsa Company Information Table 109. Sabinsa Business Overview Table 110. Sabinsa Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Sabinsa Probiotics for Middle-aged and Elderly Product Portfolio Table 112. Sabinsa Recent Development Table 113. Greentech Company Information Table 114. Greentech Business Overview Table 115. Greentech Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Greentech Probiotics for Middle-aged and Elderly Product Portfolio Table 117. Greentech Recent Development Table 118. Bioriginal Company Information Table 119. Bioriginal Business Overview Table 120. Bioriginal Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Bioriginal Probiotics for Middle-aged and Elderly Product Portfolio Table 122. Bioriginal Recent Development Table 123. Biosearch Life Company Information Table 124. Biosearch Life Business Overview Table 125. Biosearch Life Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Biosearch Life Probiotics for Middle-aged and Elderly Product Portfolio Table 127. Biosearch Life Recent Development Table 128. UAS Laboratories Company Information Table 129. UAS Laboratories Business Overview Table 130. UAS Laboratories Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. UAS Laboratories Probiotics for Middle-aged and Elderly Product Portfolio Table 132. UAS Laboratories Recent Development Table 133. Synbiotech Company Information Table 134. Synbiotech Business Overview Table 135. Synbiotech Probiotics for Middle-aged and Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Synbiotech Probiotics for Middle-aged and Elderly Product Portfolio Table 137. Synbiotech Recent Development Table 138. North America Probiotics for Middle-aged and Elderly Revenue by Type (2021-2026) & (US$ Million) Table 139. North America Probiotics for Middle-aged and Elderly Revenue by Type (2027-2032) & (US$ Million) Table 140. North America Probiotics for Middle-aged and Elderly Sales by Type (2021-2026) & (k units) Table 141. North America Probiotics for Middle-aged and Elderly Sales by Type (2027-2032) & (k units) Table 142. North America Probiotics for Middle-aged and Elderly Sales Price by Type (2021-2026) & (USD/unit) Table 143. North America Probiotics for Middle-aged and Elderly Sales Price by Type (2027-2032) & (USD/unit) Table 144. North America Probiotics for Middle-aged and Elderly Revenue by Application (2021-2026) & (US$ Million) Table 145. North America Probiotics for Middle-aged and Elderly Revenue by Application (2027-2032) & (US$ Million) Table 146. North America Probiotics for Middle-aged and Elderly Sales by Application (2021-2026) & (k units) Table 147. North America Probiotics for Middle-aged and Elderly Sales by Application (2027-2032) & (k units) Table 148. North America Probiotics for Middle-aged and Elderly Sales Price by Application (2021-2026) & (USD/unit) Table 149. North America Probiotics for Middle-aged and Elderly Sales Price by Application (2027-2032) & (USD/unit) Table 150. North America Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. North America Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. North America Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. North America Probiotics for Middle-aged and Elderly Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 154. North America Probiotics for Middle-aged and Elderly Sales by Country (2021-2026) & (k units) Table 155. North America Probiotics for Middle-aged and Elderly Sales by Country (2027-2032) & (k units) Table 156. North America Probiotics for Middle-aged and Elderly Sales Price by Country (2021-2026) & (USD/unit) Table 157. North America Probiotics for Middle-aged and Elderly Sales Price by Country (2027-2032) & (USD/unit) Table 158. United States Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 159. Canada Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 160. Mexico Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 161. Europe Probiotics for Middle-aged and Elderly Revenue by Type (2021-2026) & (US$ Million) Table 162. Europe Probiotics for Middle-aged and Elderly Revenue by Type (2027-2032) & (US$ Million) Table 163. Europe Probiotics for Middle-aged and Elderly Sales by Type (2021-2026) & (k units) Table 164. Europe Probiotics for Middle-aged and Elderly Sales by Type (2027-2032) & (k units) Table 165. Europe Probiotics for Middle-aged and Elderly Sales Price by Type (2021-2026) & (USD/unit) Table 166. Europe Probiotics for Middle-aged and Elderly Sales Price by Type (2027-2032) & (USD/unit) Table 167. Europe Probiotics for Middle-aged and Elderly Revenue by Application (2021-2026) & (US$ Million) Table 168. Europe Probiotics for Middle-aged and Elderly Revenue by Application (2027-2032) & (US$ Million) Table 169. Europe Probiotics for Middle-aged and Elderly Sales by Application (2021-2026) & (k units) Table 170. Europe Probiotics for Middle-aged and Elderly Sales by Application (2027-2032) & (k units) Table 171. Europe Probiotics for Middle-aged and Elderly Sales Price by Application (2021-2026) & (USD/unit) Table 172. Europe Probiotics for Middle-aged and Elderly Sales Price by Application (2027-2032) & (USD/unit) Table 173. Europe Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Europe Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Europe Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Europe Probiotics for Middle-aged and Elderly Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 177. Europe Probiotics for Middle-aged and Elderly Sales by Country (2021-2026) & (k units) Table 178. Europe Probiotics for Middle-aged and Elderly Sales by Country (2027-2032) & (k units) Table 179. Europe Probiotics for Middle-aged and Elderly Sales Price by Country (2021-2026) & (USD/unit) Table 180. Europe Probiotics for Middle-aged and Elderly Sales Price by Country (2027-2032) & (USD/unit) Table 181. Germany Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 182. France Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 183. U.K. Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 184. Italy Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 185. Russia Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 186. Spain Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 187. Netherlands Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 188. Switzerland Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 189. Sweden Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 190. Poland Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 191. China Probiotics for Middle-aged and Elderly Revenue by Type (2021-2026) & (US$ Million) Table 192. China Probiotics for Middle-aged and Elderly Revenue by Type (2027-2032) & (US$ Million) Table 193. China Probiotics for Middle-aged and Elderly Sales by Type (2021-2026) & (k units) Table 194. China Probiotics for Middle-aged and Elderly Sales by Type (2027-2032) & (k units) Table 195. China Probiotics for Middle-aged and Elderly Sales Price by Type (2021-2026) & (USD/unit) Table 196. China Probiotics for Middle-aged and Elderly Sales Price by Type (2027-2032) & (USD/unit) Table 197. China Probiotics for Middle-aged and Elderly Revenue by Application (2021-2026) & (US$ Million) Table 198. China Probiotics for Middle-aged and Elderly Revenue by Application (2027-2032) & (US$ Million) Table 199. China Probiotics for Middle-aged and Elderly Sales by Application (2021-2026) & (k units) Table 200. China Probiotics for Middle-aged and Elderly Sales by Application (2027-2032) & (k units) Table 201. China Probiotics for Middle-aged and Elderly Sales Price by Application (2021-2026) & (USD/unit) Table 202. China Probiotics for Middle-aged and Elderly Sales Price by Application (2027-2032) & (USD/unit) Table 203. Asia Probiotics for Middle-aged and Elderly Revenue by Type (2021-2026) & (US$ Million) Table 204. Asia Probiotics for Middle-aged and Elderly Revenue by Type (2027-2032) & (US$ Million) Table 205. Asia Probiotics for Middle-aged and Elderly Sales by Type (2021-2026) & (k units) Table 206. Asia Probiotics for Middle-aged and Elderly Sales by Type (2027-2032) & (k units) Table 207. Asia Probiotics for Middle-aged and Elderly Sales Price by Type (2021-2026) & (USD/unit) Table 208. Asia Probiotics for Middle-aged and Elderly Sales Price by Type (2027-2032) & (USD/unit) Table 209. Asia Probiotics for Middle-aged and Elderly Revenue by Application (2021-2026) & (US$ Million) Table 210. Asia Probiotics for Middle-aged and Elderly Revenue by Application (2027-2032) & (US$ Million) Table 211. Asia Probiotics for Middle-aged and Elderly Sales by Application (2021-2026) & (k units) Table 212. Asia Probiotics for Middle-aged and Elderly Sales by Application (2027-2032) & (k units) Table 213. Asia Probiotics for Middle-aged and Elderly Sales Price by Application (2021-2026) & (USD/unit) Table 214. Asia Probiotics for Middle-aged and Elderly Sales Price by Application (2027-2032) & (USD/unit) Table 215. Asia Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. Asia Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. Asia Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. Asia Probiotics for Middle-aged and Elderly Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 219. Asia Probiotics for Middle-aged and Elderly Sales by Country (2021-2026) & (k units) Table 220. Asia Probiotics for Middle-aged and Elderly Sales by Country (2027-2032) & (k units) Table 221. Asia Probiotics for Middle-aged and Elderly Sales Price by Country (2021-2026) & (USD/unit) Table 222. Asia Probiotics for Middle-aged and Elderly Sales Price by Country (2027-2032) & (USD/unit) Table 223. Japan Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 224. South Korea Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 225. India Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 226. Australia Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 227. Taiwan Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 228. Southeast Asia Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 229. SAMEA Probiotics for Middle-aged and Elderly Revenue by Type (2021-2026) & (US$ Million) Table 230. SAMEA Probiotics for Middle-aged and Elderly Revenue by Type (2027-2032) & (US$ Million) Table 231. SAMEA Probiotics for Middle-aged and Elderly Sales by Type (2021-2026) & (k units) Table 232. SAMEA Probiotics for Middle-aged and Elderly Sales by Type (2027-2032) & (k units) Table 233. SAMEA Probiotics for Middle-aged and Elderly Sales Price by Type (2021-2026) & (USD/unit) Table 234. SAMEA Probiotics for Middle-aged and Elderly Sales Price by Type (2027-2032) & (USD/unit) Table 235. SAMEA Probiotics for Middle-aged and Elderly Revenue by Application (2021-2026) & (US$ Million) Table 236. SAMEA Probiotics for Middle-aged and Elderly Revenue by Application (2027-2032) & (US$ Million) Table 237. SAMEA Probiotics for Middle-aged and Elderly Sales by Application (2021-2026) & (k units) Table 238. SAMEA Probiotics for Middle-aged and Elderly Sales by Application (2027-2032) & (k units) Table 239. SAMEA Probiotics for Middle-aged and Elderly Sales Price by Application (2021-2026) & (USD/unit) Table 240. SAMEA Probiotics for Middle-aged and Elderly Sales Price by Application (2027-2032) & (USD/unit) Table 241. SAMEA Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 242. SAMEA Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 243. SAMEA Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 244. SAMEA Probiotics for Middle-aged and Elderly Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 245. SAMEA Probiotics for Middle-aged and Elderly Sales by Country (2021-2026) & (k units) Table 246. SAMEA Probiotics for Middle-aged and Elderly Sales by Country (2027-2032) & (k units) Table 247. SAMEA Probiotics for Middle-aged and Elderly Sales Price by Country (2021-2026) & (USD/unit) Table 248. SAMEA Probiotics for Middle-aged and Elderly Sales Price by Country (2027-2032) & (USD/unit) Table 249. Brazil Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 250. Argentina Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 251. Chile Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 252. Colombia Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 253. Peru Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 254. Saudi Arabia Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 255. Israel Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 256. UAE Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 257. Turkey Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 258. Iran Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 259. Egypt Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Table 260. Key Raw Materials Table 261. Raw Materials Key Suppliers Table 262. Probiotics for Middle-aged and Elderly Distributors List Table 263. Probiotics for Middle-aged and Elderly Customers List Table 264. Research Programs/Design for This Report Table 265. Authors List of This Report Table 266. Secondary Sources Table 267. Primary Sources List of Figures Figure 1. Probiotics for Middle-aged and Elderly Image Figure 2. Global Probiotics for Middle-aged and Elderly Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Probiotics for Middle-aged and Elderly Market Size Share 2021 VS 2025 VS 2032 Figure 4. Lactic Acid Bacteria Image Figure 5. Bifidobacterium Image Figure 6. Others Image Figure 7. Global Probiotics for Middle-aged and Elderly Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Probiotics for Middle-aged and Elderly Market Size Share 2021 VS 2025 VS 2032 Figure 9. Supermarket Image Figure 10. Online Retail Image Figure 11. Others Image Figure 12. Global Probiotics for Middle-aged and Elderly Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Probiotics for Middle-aged and Elderly Revenue (2021-2032) & (US$ Million) Figure 14. Global Probiotics for Middle-aged and Elderly Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Region (2021-2032) Figure 17. Global Probiotics for Middle-aged and Elderly Sales (2021-2032) & (k units) Figure 18. Global Probiotics for Middle-aged and Elderly Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Probiotics for Middle-aged and Elderly Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Probiotics for Middle-aged and Elderly Sales YoY (2021-2032) & (k units) Figure 21. Europe Probiotics for Middle-aged and Elderly Sales YoY (2021-2032) & (k units) Figure 22. China Probiotics for Middle-aged and Elderly Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Probiotics for Middle-aged and Elderly Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Probiotics for Middle-aged and Elderly Sales YoY (2021-2032) & (k units) Figure 25. Global Probiotics for Middle-aged and Elderly Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Probiotics for Middle-aged and Elderly Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Probiotics for Middle-aged and Elderly Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Type (2021-2032) Figure 31. Global Probiotics for Middle-aged and Elderly Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Probiotics for Middle-aged and Elderly Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Probiotics for Middle-aged and Elderly Sales Market Share by Type (2021-2032) Figure 34. Global Probiotics for Middle-aged and Elderly Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Probiotics for Middle-aged and Elderly Revenue Market Share by Application (2021-2032) Figure 37. Global Probiotics for Middle-aged and Elderly Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Probiotics for Middle-aged and Elderly Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Probiotics for Middle-aged and Elderly Sales Market Share by Application (2021-2032) Figure 40. North America Probiotics for Middle-aged and Elderly Revenue Share by Type (2021-2032) Figure 41. North America Probiotics for Middle-aged and Elderly Sales Share by Type (2021-2032) Figure 42. North America Probiotics for Middle-aged and Elderly Revenue Share by Application (2021-2032) Figure 43. North America Probiotics for Middle-aged and Elderly Sales Share by Application (2021-2032) Figure 44. North America Probiotics for Middle-aged and Elderly Revenue Share by Country (2021-2032) Figure 45. North America Probiotics for Middle-aged and Elderly Sales Share by Country (2021-2032) Figure 46. Europe Probiotics for Middle-aged and Elderly Revenue Share by Type (2021-2032) Figure 47. Europe Probiotics for Middle-aged and Elderly Sales Share by Type (2021-2032) Figure 48. Europe Probiotics for Middle-aged and Elderly Revenue Share by Application (2021-2032) Figure 49. Europe Probiotics for Middle-aged and Elderly Sales Share by Application (2021-2032) Figure 50. Europe Probiotics for Middle-aged and Elderly Revenue Share by Country (2021-2032) Figure 51. Europe Probiotics for Middle-aged and Elderly Sales Share by Country (2021-2032) Figure 52. China Probiotics for Middle-aged and Elderly Revenue Share by Type (2021-2032) Figure 53. China Probiotics for Middle-aged and Elderly Sales Share by Type (2021-2032) Figure 54. China Probiotics for Middle-aged and Elderly Revenue Share by Application (2021-2032) Figure 55. China Probiotics for Middle-aged and Elderly Sales Share by Application (2021-2032) Figure 56. Asia Probiotics for Middle-aged and Elderly Revenue Share by Type (2021-2032) Figure 57. Asia Probiotics for Middle-aged and Elderly Sales Share by Type (2021-2032) Figure 58. Asia Probiotics for Middle-aged and Elderly Revenue Share by Application (2021-2032) Figure 59. Asia Probiotics for Middle-aged and Elderly Sales Share by Application (2021-2032) Figure 60. Asia Probiotics for Middle-aged and Elderly Revenue Share by Country (2021-2032) Figure 61. Asia Probiotics for Middle-aged and Elderly Sales Share by Country (2021-2032) Figure 62. SAMEA Probiotics for Middle-aged and Elderly Revenue Share by Type (2021-2032) Figure 63. SAMEA Probiotics for Middle-aged and Elderly Sales Share by Type (2021-2032) Figure 64. SAMEA Probiotics for Middle-aged and Elderly Revenue Share by Application (2021-2032) Figure 65. SAMEA Probiotics for Middle-aged and Elderly Sales Share by Application (2021-2032) Figure 66. SAMEA Probiotics for Middle-aged and Elderly Revenue Share by Country (2021-2032) Figure 67. SAMEA Probiotics for Middle-aged and Elderly Sales Share by Country (2021-2032) Figure 68. Probiotics for Middle-aged and Elderly Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Probiotics for Middle-aged and Elderly Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Lactic Acid Bacteria
  • Bifidobacterium
  • Others
Applications
  • Supermarket
  • Online Retail
  • Others
Companies covered
  • DuPont(Danisco)
  • Chr. Hansen
  • China-Biotics
  • Nestle
  • Danone
  • BioGaia
  • OMNi-BiOTiC
  • Glory Biotech
  • Ganeden
  • Morinaga Milk Industry
  • Sabinsa
  • Greentech
  • Bioriginal
  • Biosearch Life
  • UAS Laboratories
  • Synbiotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Probiotics for Middle-aged and Elderly Market by Type
  3. 1.2.1 Global Probiotics for Middle-aged and Elderly Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Lactic Acid Bacteria
  5. 1.2.3 Bifidobacterium
  6. 1.2.4 Others
  7. 1.3 Probiotics for Middle-aged and Elderly Market by Application
  8. 1.3.1 Global Probiotics for Middle-aged and Elderly Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Supermarket
  10. 1.3.3 Online Retail
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Probiotics for Middle-aged and Elderly Market Dynamics
  1. 2.1 Probiotics for Middle-aged and Elderly Industry Trends
  2. 2.2 Probiotics for Middle-aged and Elderly Industry Drivers
  3. 2.3 Probiotics for Middle-aged and Elderly Industry Opportunities and Challenges
  4. 2.4 Probiotics for Middle-aged and Elderly Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Probiotics for Middle-aged and Elderly Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Probiotics for Middle-aged and Elderly Revenue by Region
  3. 3.2.1 Global Probiotics for Middle-aged and Elderly Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Probiotics for Middle-aged and Elderly Revenue by Region (2021-2026)
  5. 3.2.3 Global Probiotics for Middle-aged and Elderly Revenue by Region (2027-2032)
  6. 3.2.4 Global Probiotics for Middle-aged and Elderly Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Probiotics for Middle-aged and Elderly Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Probiotics for Middle-aged and Elderly Sales by Region
  9. 3.4.1 Global Probiotics for Middle-aged and Elderly Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Probiotics for Middle-aged and Elderly Sales by Region (2021-2026)
  11. 3.4.3 Global Probiotics for Middle-aged and Elderly Sales by Region (2027-2032)
  12. 3.4.4 Global Probiotics for Middle-aged and Elderly Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Probiotics for Middle-aged and Elderly Revenue by Manufacturers
  2. 4.1.1 Global Probiotics for Middle-aged and Elderly Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Probiotics for Middle-aged and Elderly Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Probiotics for Middle-aged and Elderly Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Probiotics for Middle-aged and Elderly Sales by Manufacturers
  6. 4.2.1 Global Probiotics for Middle-aged and Elderly Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Probiotics for Middle-aged and Elderly Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Probiotics for Middle-aged and Elderly Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Probiotics for Middle-aged and Elderly Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Probiotics for Middle-aged and Elderly Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Probiotics for Middle-aged and Elderly Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Probiotics for Middle-aged and Elderly Manufacturers, Product Type & Application
  13. 4.7 Global Probiotics for Middle-aged and Elderly Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Probiotics for Middle-aged and Elderly Market CR5 and HHI
  16. 4.8.2 2025 Probiotics for Middle-aged and Elderly Tier 1, Tier 2, and Tier 3
5 Probiotics for Middle-aged and Elderly Market by Type
  1. 5.1 Global Probiotics for Middle-aged and Elderly Revenue by Type
  2. 5.1.1 Global Probiotics for Middle-aged and Elderly Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Probiotics for Middle-aged and Elderly Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Probiotics for Middle-aged and Elderly Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Probiotics for Middle-aged and Elderly Sales by Type
  6. 5.2.1 Global Probiotics for Middle-aged and Elderly Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Probiotics for Middle-aged and Elderly Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Probiotics for Middle-aged and Elderly Sales Market Share by Type (2021-2032)
  9. 5.3 Global Probiotics for Middle-aged and Elderly Price by Type
6 Probiotics for Middle-aged and Elderly Market by Application
  1. 6.1 Global Probiotics for Middle-aged and Elderly Revenue by Application
  2. 6.1.1 Global Probiotics for Middle-aged and Elderly Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Probiotics for Middle-aged and Elderly Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Probiotics for Middle-aged and Elderly Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Probiotics for Middle-aged and Elderly Sales by Application
  6. 6.2.1 Global Probiotics for Middle-aged and Elderly Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Probiotics for Middle-aged and Elderly Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Probiotics for Middle-aged and Elderly Sales Market Share by Application (2021-2032)
  9. 6.3 Global Probiotics for Middle-aged and Elderly Price by Application
7 Company Profiles
  1. 7.1 DuPont(Danisco)
  2. 7.1.1 DuPont(Danisco) Company Information
  3. 7.1.2 DuPont(Danisco) Business Overview
  4. 7.1.3 DuPont(Danisco) Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 DuPont(Danisco) Probiotics for Middle-aged and Elderly Product Portfolio
  6. 7.1.5 DuPont(Danisco) Recent Developments
  7. 7.2 Chr. Hansen
  8. 7.2.1 Chr. Hansen Company Information
  9. 7.2.2 Chr. Hansen Business Overview
  10. 7.2.3 Chr. Hansen Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Chr. Hansen Probiotics for Middle-aged and Elderly Product Portfolio
  12. 7.2.5 Chr. Hansen Recent Developments
  13. 7.3 China-Biotics
  14. 7.3.1 China-Biotics Company Information
  15. 7.3.2 China-Biotics Business Overview
  16. 7.3.3 China-Biotics Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 China-Biotics Probiotics for Middle-aged and Elderly Product Portfolio
  18. 7.3.5 China-Biotics Recent Developments
  19. 7.4 Nestle
  20. 7.4.1 Nestle Company Information
  21. 7.4.2 Nestle Business Overview
  22. 7.4.3 Nestle Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Nestle Probiotics for Middle-aged and Elderly Product Portfolio
  24. 7.4.5 Nestle Recent Developments
  25. 7.5 Danone
  26. 7.5.1 Danone Company Information
  27. 7.5.2 Danone Business Overview
  28. 7.5.3 Danone Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Danone Probiotics for Middle-aged and Elderly Product Portfolio
  30. 7.5.5 Danone Recent Developments
  31. 7.6 BioGaia
  32. 7.6.1 BioGaia Company Information
  33. 7.6.2 BioGaia Business Overview
  34. 7.6.3 BioGaia Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 BioGaia Probiotics for Middle-aged and Elderly Product Portfolio
  36. 7.6.5 BioGaia Recent Developments
  37. 7.7 OMNi-BiOTiC
  38. 7.7.1 OMNi-BiOTiC Company Information
  39. 7.7.2 OMNi-BiOTiC Business Overview
  40. 7.7.3 OMNi-BiOTiC Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 OMNi-BiOTiC Probiotics for Middle-aged and Elderly Product Portfolio
  42. 7.7.5 OMNi-BiOTiC Recent Developments
  43. 7.8 Glory Biotech
  44. 7.8.1 Glory Biotech Company Information
  45. 7.8.2 Glory Biotech Business Overview
  46. 7.8.3 Glory Biotech Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Glory Biotech Probiotics for Middle-aged and Elderly Product Portfolio
  48. 7.8.5 Glory Biotech Recent Developments
  49. 7.9 Ganeden
  50. 7.9.1 Ganeden Company Information
  51. 7.9.2 Ganeden Business Overview
  52. 7.9.3 Ganeden Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Ganeden Probiotics for Middle-aged and Elderly Product Portfolio
  54. 7.9.5 Ganeden Recent Developments
  55. 7.10 Morinaga Milk Industry
  56. 7.10.1 Morinaga Milk Industry Company Information
  57. 7.10.2 Morinaga Milk Industry Business Overview
  58. 7.10.3 Morinaga Milk Industry Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Morinaga Milk Industry Probiotics for Middle-aged and Elderly Product Portfolio
  60. 7.10.5 Morinaga Milk Industry Recent Developments
  61. 7.11 Sabinsa
  62. 7.11.1 Sabinsa Company Information
  63. 7.11.2 Sabinsa Business Overview
  64. 7.11.3 Sabinsa Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sabinsa Probiotics for Middle-aged and Elderly Product Portfolio
  66. 7.11.5 Sabinsa Recent Developments
  67. 7.12 Greentech
  68. 7.12.1 Greentech Company Information
  69. 7.12.2 Greentech Business Overview
  70. 7.12.3 Greentech Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Greentech Probiotics for Middle-aged and Elderly Product Portfolio
  72. 7.12.5 Greentech Recent Developments
  73. 7.13 Bioriginal
  74. 7.13.1 Bioriginal Company Information
  75. 7.13.2 Bioriginal Business Overview
  76. 7.13.3 Bioriginal Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Bioriginal Probiotics for Middle-aged and Elderly Product Portfolio
  78. 7.13.5 Bioriginal Recent Developments
  79. 7.14 Biosearch Life
  80. 7.14.1 Biosearch Life Company Information
  81. 7.14.2 Biosearch Life Business Overview
  82. 7.14.3 Biosearch Life Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Biosearch Life Probiotics for Middle-aged and Elderly Product Portfolio
  84. 7.14.5 Biosearch Life Recent Developments
  85. 7.15 UAS Laboratories
  86. 7.15.1 UAS Laboratories Company Information
  87. 7.15.2 UAS Laboratories Business Overview
  88. 7.15.3 UAS Laboratories Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 UAS Laboratories Probiotics for Middle-aged and Elderly Product Portfolio
  90. 7.15.5 UAS Laboratories Recent Developments
  91. 7.16 Synbiotech
  92. 7.16.1 Synbiotech Company Information
  93. 7.16.2 Synbiotech Business Overview
  94. 7.16.3 Synbiotech Probiotics for Middle-aged and Elderly Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Synbiotech Probiotics for Middle-aged and Elderly Product Portfolio
  96. 7.16.5 Synbiotech Recent Developments
8 North America
  1. 8.1 North America Probiotics for Middle-aged and Elderly Market Size by Type
  2. 8.1.1 North America Probiotics for Middle-aged and Elderly Revenue by Type (2021-2032)
  3. 8.1.2 North America Probiotics for Middle-aged and Elderly Sales by Type (2021-2032)
  4. 8.1.3 North America Probiotics for Middle-aged and Elderly Price by Type (2021-2032)
  5. 8.2 North America Probiotics for Middle-aged and Elderly Market Size by Application
  6. 8.2.1 North America Probiotics for Middle-aged and Elderly Revenue by Application (2021-2032)
  7. 8.2.2 North America Probiotics for Middle-aged and Elderly Sales by Application (2021-2032)
  8. 8.2.3 North America Probiotics for Middle-aged and Elderly Price by Application (2021-2032)
  9. 8.3 North America Probiotics for Middle-aged and Elderly Market Size by Country
  10. 8.3.1 North America Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Probiotics for Middle-aged and Elderly Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Probiotics for Middle-aged and Elderly Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Probiotics for Middle-aged and Elderly Market Size by Type
  2. 9.1.1 Europe Probiotics for Middle-aged and Elderly Revenue by Type (2021-2032)
  3. 9.1.2 Europe Probiotics for Middle-aged and Elderly Sales by Type (2021-2032)
  4. 9.1.3 Europe Probiotics for Middle-aged and Elderly Price by Type (2021-2032)
  5. 9.2 Europe Probiotics for Middle-aged and Elderly Market Size by Application
  6. 9.2.1 Europe Probiotics for Middle-aged and Elderly Revenue by Application (2021-2032)
  7. 9.2.2 Europe Probiotics for Middle-aged and Elderly Sales by Application (2021-2032)
  8. 9.2.3 Europe Probiotics for Middle-aged and Elderly Price by Application (2021-2032)
  9. 9.3 Europe Probiotics for Middle-aged and Elderly Market Size by Country
  10. 9.3.1 Europe Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Probiotics for Middle-aged and Elderly Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Probiotics for Middle-aged and Elderly Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Probiotics for Middle-aged and Elderly Market Size by Type
  2. 10.1.1 China Probiotics for Middle-aged and Elderly Revenue by Type (2021-2032)
  3. 10.1.2 China Probiotics for Middle-aged and Elderly Sales by Type (2021-2032)
  4. 10.1.3 China Probiotics for Middle-aged and Elderly Price by Type (2021-2032)
  5. 10.2 China Probiotics for Middle-aged and Elderly Market Size by Application
  6. 10.2.1 China Probiotics for Middle-aged and Elderly Revenue by Application (2021-2032)
  7. 10.2.2 China Probiotics for Middle-aged and Elderly Sales by Application (2021-2032)
  8. 10.2.3 China Probiotics for Middle-aged and Elderly Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Probiotics for Middle-aged and Elderly Market Size by Type
  2. 11.1.1 Asia Probiotics for Middle-aged and Elderly Revenue by Type (2021-2032)
  3. 11.1.2 Asia Probiotics for Middle-aged and Elderly Sales by Type (2021-2032)
  4. 11.1.3 Asia Probiotics for Middle-aged and Elderly Price by Type (2021-2032)
  5. 11.2 Asia Probiotics for Middle-aged and Elderly Market Size by Application
  6. 11.2.1 Asia Probiotics for Middle-aged and Elderly Revenue by Application (2021-2032)
  7. 11.2.2 Asia Probiotics for Middle-aged and Elderly Sales by Application (2021-2032)
  8. 11.2.3 Asia Probiotics for Middle-aged and Elderly Price by Application (2021-2032)
  9. 11.3 Asia Probiotics for Middle-aged and Elderly Market Size by Country
  10. 11.3.1 Asia Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Probiotics for Middle-aged and Elderly Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Probiotics for Middle-aged and Elderly Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Probiotics for Middle-aged and Elderly Market Size by Type
  2. 12.1.1 SAMEA Probiotics for Middle-aged and Elderly Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Probiotics for Middle-aged and Elderly Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Probiotics for Middle-aged and Elderly Price by Type (2021-2032)
  5. 12.2 SAMEA Probiotics for Middle-aged and Elderly Market Size by Application
  6. 12.2.1 SAMEA Probiotics for Middle-aged and Elderly Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Probiotics for Middle-aged and Elderly Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Probiotics for Middle-aged and Elderly Price by Application (2021-2032)
  9. 12.3 SAMEA Probiotics for Middle-aged and Elderly Market Size by Country
  10. 12.3.1 SAMEA Probiotics for Middle-aged and Elderly Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Probiotics for Middle-aged and Elderly Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Probiotics for Middle-aged and Elderly Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Probiotics for Middle-aged and Elderly Value Chain Analysis
  2. 13.1.1 Probiotics for Middle-aged and Elderly Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Probiotics for Middle-aged and Elderly Production Mode & Process
  6. 13.2 Probiotics for Middle-aged and Elderly Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Probiotics for Middle-aged and Elderly Distributors
  9. 13.2.3 Probiotics for Middle-aged and Elderly Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst